Melanie Ayala Ceja

CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Patricia A. Young, Christopher M. Walthers, S. de Vos, 2022, medRxiv.

CAR-T cell manufacturing: Major process parameters and next-generation strategies

Y. Chen, C. Puig-Saus, M. Khericha, 2024, The Journal of experimental medicine.

Self-regulating CAR-T cells modulate cytokine release syndrome in adoptive T-cell therapy.

Y. Chen, M. Khericha, Amanda Shafer, 2024, The Journal of experimental medicine.